Reporting owner · CIK 0000886982
Goldman Sachs Group Inc
Visual SEC Form 4 history across 2 companies, 36 transactions and 2 filings.
10%Attovia Therapeutics, Inc.
Open-market mix
25%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Jan 26
−$15M
Aug 26
$10.3M
Transaction texture
Ownership and ticket size
Average P/S size$930.8K
Median P/S size$25.8K
Direct0
Indirect36
Aug 06, 2026unknown
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Attovia Therapeutics, Inc. on Aug 06, 2026 valued at $8,500,000.
Review SEC filingLatest sale
sale at Attovia Therapeutics, Inc. on Aug 05, 2026 valued at $1,607,835.
Review SEC filingAssociated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ATTO | GOLDMAN SACHS GROUP INC | 10% | sale | 200 | -$441k | S | — | 08/28 | 08/05 | |
| ATTO | GOLDMAN SACHS GROUP INC | 10% | sale | 1.33k | -$2.93M | S | — | 08/28 | 08/05 | |
| ATTO | GOLDMAN SACHS GROUP INC | 10% | sale | 447 | -$977k | S | — | 08/28 | 08/05 | |
| ATTO | GOLDMAN SACHS GROUP INC | 10% | sale | 988 | -$2.17M | S | — | 08/28 | 08/05 | |
| ATTO | GOLDMAN SACHS GROUP INC | 10% | buy | 85.0k | $178M | P | — | 08/28 | 08/05 | |
| SHCO | GOLDMAN SACHS GROUP INC | 10% | sale | 1.66M | -$1.49B | S | 0.0% | 02/02 | 01/29 |
Goldman Sachs Group Inc Insider Activity FAQ
SEC Form 4 context
Who is Goldman Sachs Group Inc?
Goldman Sachs Group Inc is a reporting owner in SEC Form 4 filings with reporting owner CIK 0000886982.
Which companies has Goldman Sachs Group Inc reported transactions for?
Attovia Therapeutics, Inc., Soho House & Co Inc.
When was Goldman Sachs Group Inc's latest insider buy?
buy at Attovia Therapeutics, Inc. on Aug 06, 2026 valued at $8,500,000.
When was Goldman Sachs Group Inc's latest insider sale?
sale at Attovia Therapeutics, Inc. on Aug 05, 2026 valued at $1,607,835.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.